BHB
TARO

Bank Hapoalim BM’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bank Hapoalim BM’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,390
Closed -$214K – 169
2014
Q3 		$214K Sell
1,390
-400
-22% -$60.2K 0.05% 150
2014
Q2 		$251K Sell
1,790
-55
-3% -$6.11K 0.06% 131
2014
Q1 		$205K Sell
1,845
-835
-31% -$90.9K 0.06% 137
2013
Q4 		$265K Buy
+2,680
New +$232K 0.08% 118

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank Hapoalim BM's TARO Position: Q4 2014 in Review

Bank Hapoalim BM sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2014, closing a stake of 1,390 shares — an estimated $214K sold.

Bank Hapoalim BM first reported a position in TARO in Q4 2013 and held it in 4 quarters. The position peaked at $265K in Q4 2013. 89 funds tracked by Wall St. Rank hold TARO as of Q4 2014.

  • Bank Hapoalim BM reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2014 after selling out during the quarter.
  • Bank Hapoalim BM sold 1,390 Taro Pharmaceutical Industries Ltd. shares in Q4 2014, an estimated $214K.
  • Bank Hapoalim BM first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 4 quarters.
  • Bank Hapoalim BM's Taro Pharmaceutical Industries Ltd. position peaked at $265K in Q4 2013.
  • 89 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2014.

Based on Bank Hapoalim BM's 13F filing for Q4 2014, filed 2 Feb 2015.